Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience
2017; Soc for Publication of Acta Dermato-Venereologica; Volume: 97; Issue: 8 Linguagem: Inglês
10.2340/00015555-2698
ISSN1651-2057
AutoresFederico Bardazzi, Michela Magnano, A Campanati, Francesco Loconsole, Antonio Carpentieri, Concetta Potenza, Nicoletta Bernardini, Vito Di Lernia, Carlo Giovanni Carrera, Beatrice Raone, Annalisa Patrizi, Camilla Loi,
Tópico(s)Spondyloarthritis Studies and Treatments
Resumowww.medicaljournals.se/actaterm infectious complications in HIV-infected patients and then, if these are not effective or are contraindicated, switch to an interleukin (IL)-12/23 inhibitor.This is the largest case series reported so far of HIVinfected patients treated with biologics, with one of the longest follow-ups.Although the number of cases is still limited, we believe that the use of biologic agents may be considered a possible effective choice in psoriatic patients with a stable HIV infection.It is also mandatory to monitor CD4 count and HIV viral load, in order to avoid possible causes of infections.The authors declare no conflicts of interest.
Referência(s)